E-LIB Suche - Ergebnisse für: Gosselin, Nathalie H

1

Estimating potential cardiovascular health benefits of impr..:

Ray, Kausik K. ; Gunn, Laura H. ; Conde, Lorena Garcia...
Atherosclerosis. 391 (2024) - p. 117472 , 2024

2

Translational Population‐Pharmacodynamic Modeling of a Nove..:

Gosselin, Nathalie H. ; Schuck, Virna J. A. ; Barriere, Olivier...
Clinical Pharmacology & Therapeutics. 113 (2022) 2 - p. 328-338 , 2022

Link: https://doi.org/10.1002/..

3

Population Pharmacokinetics of Heptanoate in Healthy Subjec..:

Lee, Sun Ku ; Gosselin, Nathalie H. ; Jomphe, Claudia..
Clinical Pharmacology in Drug Development. 11 (2022) 11 - p. 1264-1272 , 2022

Link: https://doi.org/10.1002/..

4

Population Pharmacokinetics and Exposure–Response Relations..:

Song, Ivy ; Chen, Grace ; Hayes, Siobhan...
Transplantation and Cellular Therapy. 28 (2022) 3 - p. S368-S369 , 2022

Link: https://doi.org/10.1016/..

5

Population Pharmacokinetics and Pharmacodynamics of Burosum..:

Lee, Sun Ku ; Gosselin, Nathalie H. ; Taylor, Julie...
The Journal of Clinical Pharmacology. 62 (2021) 1 - p. 87-98 , 2021

Link: https://doi.org/10.1002/..

6

Randomized Population Pharmacokinetic Analysis and Safety o..:

Hammer, Gregory B. ; Maxwell, Lynne G. ; Taicher, Brad M....
The Journal of Clinical Pharmacology. 60 (2019) 1 - p. 16-27 , 2019

Link: https://doi.org/10.1002/..

7

A randomized, double‐blind, placebo‐controlled, pharmacokin..:

Hsia, Daniel S. ; Gosselin, Nathalie H. ; Williams, Jenna...
Diabetes, Obesity and Metabolism. 22 (2019) 4 - p. 480-491 , 2019

Link: https://doi.org/10.1111/..

8

Exposure-Response Analyses of Lanadelumab in Patients with ..:

Wang, Yi ; Marier, Jean-Francois ; Kassir, Nastya..
Journal of Allergy and Clinical Immunology. 143 (2019) 2 - p. AB40 , 2019

Link: https://doi.org/10.1016/..

9

Population pharmacokinetics of bevacizumab in cancer patien..:

Han, Kelong ; Peyret, Thomas ; Marchand, Mathilde...
Cancer Chemotherapy and Pharmacology. 78 (2016) 2 - p. 341-351 , 2016

Link: https://doi.org/10.1007/..

10

Population pharmacokinetic and pharmacodynamic analyses fro..:

Zhang, Xiaoping ; Peyret, Thomas ; Gosselin, Nathalie H....
The Journal of Clinical Pharmacology. 56 (2015) 4 - p. 429-438 , 2015

Link: https://doi.org/10.1002/..

11

Bevacizumab dosing strategy in paediatric cancer patients b..:

Han, Kelong ; Peyret, Thomas ; Quartino, Angelica...
British Journal of Clinical Pharmacology. 81 (2015) 1 - p. 148-160 , 2015

Link: https://doi.org/10.1111/..

12

Population pharmacokinetic modeling of motesanib and its ac..:

Gosselin, Nathalie H. ; Mouksassi, Mohamad‐Samer ; Lu, Jian‐Feng.
Clinical Pharmacology in Drug Development. 4 (2015) 6 - p. 463-472 , 2015

Link: https://doi.org/10.1002/..

13

Population pharmacokinetic analysis of dutogliptin, a selec..:

Marier, Jean‐Francois ; Mouksassi, Mohamad‐Samer ; Gosselin, Nathalie H..
Clinical Pharmacology in Drug Development. 3 (2014) 4 - p. 297-304 , 2014

Link: https://doi.org/10.1002/..

14

Differential Pharmacokinetics of Ganitumab in Patients With..:

Zhu, Min ; Gosselin, Nathalie H. ; Kuchimanchi, Mita...
Clinical Pharmacology in Drug Development. 2 (2013) 4 - p. 367-378 , 2013

Link: https://doi.org/10.1002/..

15

Relationship between prenatal exposure to polychlorinated b..:

El Majidi, Naïma ; Bouchard, Michèle ; Gosselin, Nathalie H..
Regulatory Toxicology and Pharmacology. 64 (2012) 1 - p. 161-176 , 2012

Link: https://doi.org/10.1016/..